The changes of leukocyte telomere length and telomerase activity after sitagliptin intervention in newly diagnosed type 2 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 31, Issue 3, 2015, Pages 256-261

  Ma, Delin ^a   Yu, Yuan ^a   Yu, Xuefeng ^a   Zhang, Muxun ^a   Yang, Yan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Sitagliptin; Telomerase; Telomere; Type 2 diabetes

Indexed keywords

SITAGLIPTIN; TELOMERASE; ANTIDIABETIC AGENT; TERT PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEUKOCYTE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TELOMERE; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; ENZYMOLOGY; FOLLOW UP; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TELOMERE HOMEOSTASIS;

ADULT; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LEUKOCYTES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; SITAGLIPTIN PHOSPHATE; TELOMERASE; TELOMERE HOMEOSTASIS;

EID: 84924256354     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2578     Document Type: Article

References (31)

1. Zhao Y, Sfeir AJ, Zou Y, et al. Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell 2009; 138(3): 463-475.
2. Blackburn EH. Structure and function of telomeres. Nature 1991; 350(6319): 569-573.
3. Collins K, Mitchell JR. Telomerase in the human organism. Oncogene 2002; 21(4): 564-579.
4. Dong CK, Masutomi K, Hahn WC. Telomerase: regulation, function and transformation. Crit Rev Oncol Hematol 2005; 54(2): 85-93.
5. Finkel T, Serrano M, Blasco MA. The common biology of cancer and ageing. Nature 2007; 448(7155): 767-774.
6. Sahin E, Depinho RA. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature 2010; 464(7288): 520-528.
7. Zee RY, Castonguay AJ, Barton NS, Germer S, Martin M. Mean leukocyte telomere length shortening and type 2 diabetes mellitus: a case-control study. Transl Res 2010; 155(4): 166-169.
8. You NC, Chen BH, Song Y, et al. A prospective study of leukocyte telomere length and risk of type 2 diabetes in postmenopausal women. Diabetes 2012; 61(11): 2998-3004.
9. Salpea KD, Talmud PJ, Cooper JA, et al. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 2010; 209(1): 42-50.
10. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362(12): 1090-1101.
11. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA 2003; 290(14): 1884-1890.
12. Liew CW, Holman A, Kulkarni RN. The roles of telomeres and telomerase in beta-cell regeneration. Diabetes Obes Metab 2009; 11(Suppl 4): 21-29.
13. Adaikalakoteswari A, Balasubramanyam M, Mohan V. Telomere shortening occurs in Asian Indian type 2 diabetic patients. Diabet Med 2005; 22(9): 1151-1156.
14. Hovatta I, de Mello VD, Kananen L, et al. Leukocyte telomere length in the Finnish Diabetes Prevention Study. PLoS One 2012; 7(4): e34948.
15. Tentolouris N, Nzietchueng R, Cattan V, et al. White blood cells telomere length is shorter in males with type 2 diabetes and microalbuminuria. Diabetes Care 2007; 30(11): 2909-2915.
16. Tarry-Adkins JL, Chen JH, Smith NS, Jones RH, Cherif H, Ozanne SE. Poor maternal nutrition followed by accelerated postnatal growth leads to telomere shortening and increased markers of cell senescence in rat islets. FASEB J 2009; 23(5): 1521-1528.
17. Kuhlow D, Florian S, von Figura G, et al. Telomerase deficiency impairs glucose metabolism and insulin secretion. Aging (Albany NY) 2010; 2(10): 650-658.
18. Kim W, Egan JM. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev 2008; 60(4): 470-512.
19. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7): 539-553.
20. Akhter J. The American Diabetes Association's clinical practice recommendations and the developing world. Diabetes Care 1997; 20(6): 1044-1045.
21. Yang Z, Huang X, Jiang H, et al. Short telomeres and prognosis of hypertension in a Chinese population. Hypertension 2009; 53(4): 639-645.
22. Jeanclos E, Krolewski A, Skurnick J, et al. Shortened telomere length in white blood cells of patients with IDDM. Diabetes 1998; 47(3): 482-486.
23. Olivieri F, Lorenzi M, Antonicelli R, et al. Leukocyte telomere shortening in elderly type 2 DM patients with previous myocardial infarction. Atherosclerosis 2009; 206(2): 588-593.
24. Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care 2006; 29(2): 283-289.
25. Uziel O, Singer JA, Danicek V, et al. Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control. Exp Gerontol 2007; 42(10): 971-978.
26. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266(5193): 2011-2015.
27. Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155(8): 3711-3715.
28. Epel ES, Blackburn EH, Lin J, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 2004; 101(49): 17312-17315.
29. Tsirpanlis G, Chatzipanagiotou S, Boufidou F, et al. Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients. Nephrology (Carlton) 2006; 11(6): 506-509.
30. Thewissen M, Linsen L, Geusens P, Raus J, Stinissen P. Impaired activation-induced telomerase activity in PBMC of early but not chronic rheumatoid arthritis patients. Immunol Lett 2005; 100(2): 205-210.
31. Rentoukas E, Tsarouhas K, Kaplanis I, et al. Connection between telomerase activity in PBMC and markers of inflammation and endothelial dysfunction in patients with metabolic syndrome. PLoS One 2012; 7(4): e35739.